Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

379 ARTÍCULOS , VIENDO DEL 331 AL 345

A small molecule that displays marked reactivity toward copper- versus zinc-amyloid-β implicated in Alzheimer's disease

Savelieff MG, Liu Y, Senthamarai RR, Korshavn KJ, Lee HJ, Ramamoorthy A, Lim MH.

Chem Commun (Camb). 2014 May 25;50(40):5301-3. doi: 10.1039/c3cc48473d. Epub 2013 Dec 10.

Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease

El-Malah A, Gedawy EM, Kassab AE, Salam RM.

Arch Pharm (Weinheim). 2014 Feb;347(2):96-103. doi: 10.1002/ardp.201300121. Epub 2013 Dec 16.

Clusterin in Alzheimer's disease: a player in the biological behavior of amyloid-beta

Li X, Ma Y, Wei X, Li Y, Wu H, Zhuang J, Zhao Z.

Neurosci Bull. 2014 Feb;30(1):162-8. doi: 10.1007/s12264-013-1391-2. Epub 2013 Dec 19.

Tau-aggregation inhibitor therapy for Alzheimer's disease

Wischik CM, Harrington CR, Storey JM.

Biochem Pharmacol. 2014 Apr 15;88(4):529-39. doi: 10.1016/j.bcp.2013.12.008. Epub 2013 Dec 19.

Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease

Cai Z, Hussain MD, Yan LJ.

Int J Neurosci. 2014 May;124(5):307-21. doi: 10.3109/00207454.2013.833510. Epub 2013 Sep 12.

Dysfunctional synapse in Alzheimer's disease - A focus on NMDA receptors

Mota SI, Ferreira IL, Rego AC.

Neuropharmacology. 2014 Jan;76 Pt A:16-26. doi: 10.1016/j.neuropharm.2013.08.013. Epub 2013 Aug 22.

Comparison of manual and semi-automated segmentation methods to evaluate hippocampus volume in APP and PS1 transgenic mice obtained via in vivo magnetic resonance imaging

Hayes K, Buist R, Vincent TJ, Thiessen JD, Zhang Y, Zhang H, Wang J, Summers AR, Kong J, Li XM, Martin M.

J Neurosci Methods. 2014 Jan 15;221:103-11. doi: 10.1016/j.jneumeth.2013.09.014. Epub 2013 Oct 1.

Does an Alzheimer's disease susceptibility gene influence the cognitive effects of cancer therapy?

Caselli RJ.

Pediatr Blood Cancer. 2014 Oct;61(10):1739-42. doi: 10.1002/pbc.24768. Epub 2013 Sep 17.

The potential role of kynurenines in Alzheimer's disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors

Majláth Z, Toldi J, Vécsei L.

J Neural Transm (Vienna). 2014 Aug;121(8):881-9. doi: 10.1007/s00702-013-1135-5. Epub 2013 Dec 18.

Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease

Cheng X, Wu J, Geng M, Xiong J.

Neurobiol Aging. 2014 Jun;35(6):1217-32. doi: 10.1016/j.neurobiolaging.2013.11.021. Epub 2013 Nov 28.

Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease

O'Brien J, Jackson JW, Grodstein F, Blacker D, Weuve J.

Epidemiol Rev. 2014;36(1):83-103. doi: 10.1093/epirev/mxt008. Epub 2013 Sep 15.

Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele

Qiu WW, Lai A, Mon T, Mwamburi M, Taylor W, Rosenzweig J, Kowall N, Stern R, Zhu H, Steffens DC.

Am J Geriatr Psychiatry. 2014 Feb;22(2):177-85. doi: 10.1016/j.jagp.2012.08.017. Epub 2013 Apr 3.

[Rivastigmine as treatment for patients with mild to moderately severe Alzheimer disease under normal clinical practice conditions. The ENTERPRISE study]

Cruz Jentoft AJ, Hernández B.

Neurologia. 2014 Jan-Feb;29(1):1-10. doi: 10.1016/j.nrl.2013.01.008. Epub 2013 Apr 10.

Cortical changes associated with depression and antidepressant use in Alzheimer and Lewy body dementia: an MRI surface-based morphometric study

Lebedev AV, Beyer MK, Fritze F, Westman E, Ballard C, Aarsland D.

Am J Geriatr Psychiatry. 2014 Jan;22(1):4-13.e1. doi: 10.1016/j.jagp.2013.02.004. Epub 2013 Jul 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias